HHMI Erin O'Shea: Biggest influences was went to @SmithCollege as undergraduate; enormous influence. left there thinking I could do anything. carried through career [Personal note: My daughter went to Smith].
But at MIT, there was a single faculty member.
#RAForum #RAForum19
-
-
.
@theNAMedicine former#FDA Peggy Hamburg talks about@aaas If-Then Program https://ifthen.aaas.org/ https://www.aaas.org/page/ifthen-ambassadors … We want to make sure we are getting as many women/girls interested in science. We need to make sure we have the pathways.#RAForum#RAForum19#WomenInSTEMPrikaži ovu nit -
.
@theNAMedicine former#FDA Peggy Hamburg: It's important to reach kids early & provide the appropriate education In the modern era, everyone should be fully exposed to science & math education Need to look at where losing women in the system#RAForum#RAForum19#WomenInSciencePrikaži ovu nit -
$LLY Michele Oshman: Patient orgs do a good job amplifying one another' efforts So how can duplicate that for women in workforce/#WomenInScience?#RAForum#RAForum19#WomenInSTEMPrikaži ovu nit -
.
@LMaineAACP: Wouldn't@NIHDirector be very proud of this panel today! https://www.nih.gov/about-nih/who-we-are/nih-director/statements/time-end-manel-tradition …#RAForum#RAForum19#WomenInScience#WomenInSTEM#science#NIHPrikaži ovu nit -
#NIH Janine Austin Clayton: Male allies are very important for women.#RAForum#RAForum19#WomenInScience#WomenInSTEM#sciencePrikaži ovu nit -
.
@LMaineAACP: I have two men out on parental leave right now & I'm proud of that!#RAForum#RAForum19#WomenInScience#WomenInSTEM#sciencePrikaži ovu nit -
#NIH Janine Austin Clayton talks about "team science" & notes many, many global health majors are women. We do need to find a way to reward team work.#RAForum#RAForum19#WomenInScience#WomenInSTEM#sciencePrikaži ovu nit -
#NIH Janine Austin Clayton second one to note@NIHDirector said no more#manels! https://www.nih.gov/about-nih/who-we-are/nih-director/statements/time-end-manel-tradition …#RAForum#RAForum19#WomenInScience#WomenInSTEM#sciencePrikaži ovu nit -
$LLY Michele Oshman: Don't be afraid to introduce what might be traditionally thought of as male-play to young girls. Take them through a muddy creek to look for stuff.#RAForum#RAForum19#WomenInScience#WomenInSTEM#sciencePrikaži ovu nit -
.
@MDAorg Lynn O'Connor Vos: Timeline for getting drugs to market for muscular dystrophy is rapidly changing. But there's lack of docs/nurses trained in administering those drugs & caring for those patients. So .@MDAorg working on innovating care.#RAForum#RAForum19Prikaži ovu nit -
AHRQ Gopal Khanna: Important for us to partner b/c our work must get to patients.
#RAForum#RAForum19Prikaži ovu nit -
.
@RickABright: In 12 years, we have formed 250 public-private partnerships of all sizes w/ industry. Now have 48 new drugs, vaccines & diagnostics. Some in marketplace & some in SNS. We have shown this establishment has significantly reduced R&D time & cost.#RAForum#RAForum19Prikaži ovu nit -
$JNJ Innovation Melinda Richter says 26% of JLABs companies are women led 25% minority led We are trying to make sure we service everyone with most affordable & accessible care.#RAForum#RAForum19Prikaži ovu nit -
#NIH#NCATS Chris Austin: Have a mission to innovate on every step of translational process. Make those steps happen better, faster, cheaper. We always look for 10-fold improvements in everything we do. Translation is obligatory a team sport.#RAForum#RAForum19Prikaži ovu nit -
#NIH#NCATS Chris Austin: You can't do this on your own. Every project NCATS does is a collaboration. We are advocates of team science b/c translation is only going to get done if we bring in unconventional partners who complement each other.#RAForum#RAForum19Prikaži ovu nit -
#NIH#NCATS Chris Austin: There really is a lot of science not necessarily sitting on the shelf but in people's brains all over the world & we have to be open to that.#RAForum#RAForum19Prikaži ovu nit -
#NIH Chris Austin says#NCATS tries to be catalyst Our job is not to own, but work on it as little time as possible to get it out into the marketplace.#RAForum#RAForum19Prikaži ovu nit -
Elsevier Clinical Solutions Richard Loomis: Even when know what to do, how do we get those on front lines to ensure they are delivering the most important care?
#RAForum#RAForum19Prikaži ovu nit -
Elsevier Clinical Solutions Richard Loomis notes new partnership with
#NIH#NCATS https://www.elsevier.com/about/press-releases/clinical-solutions/nih-and-elsevier-strike-agreement-for-use-of-ncats-rare-disease-database-to-support-primary-care …#RAForum#RAForum19Prikaži ovu nit -
#NIH#NCATS Chris Austin: Much is known … but in different heads.#RAForum#RAForum19Prikaži ovu nit -
#AHRQ's Gopal Khanna says must engage not just medical experts, but also social science, data info experts, etc. Must take a non-traditional approach going into the future.#RAForum#RAForum19Prikaži ovu nit -
.
@RickABright: We have to give the unique partners times to understand each other's language & collide the different cultures. It's at the collision of culture where new inventions start. That's when we find those answers & celebrate discovery of solutions.#RAForum#RAForum19Prikaži ovu nit -
.
@MDAorg Lynn O'Connor Vos: Must re-position the role of advocacy orgs in the minds of commercial/academics b/c doing some major initiatives.#RAForum#RAForum19#pharma#rarediseases#rarediseasePrikaži ovu nit -
.
@MDAorg Lynn O'Connor Vos: Are we designing something that's really relevant? You think you are designing something that everybody needs, but maybe not.#RAForum#RAForum19Prikaži ovu nit -
.
@MDAorg Lynn O'Connor Vos: Nonprofit is now at the center of the ecosystem in health.#RAForum#RAForum19Prikaži ovu nit -
.
@MDAorg Lynn O'Connor Vos on collaborations: You kind of need a Jerk-O-Meter [she noted someone mentioned that at#BIO19 ]. You need to know who is on your team. Are they going to play well?#RAForum#RAForum19Prikaži ovu nit -
#NIH#NCATS Chris Austin: Most players are rewarded for some intermediate outcome & not the ultimate outcome. That's a problem.#RAForum#RAforum19Prikaži ovu nit -
Wow,
#NIH#Chris Austin talks about a drugmaker#NCATS worked met the milestones & once objective met, then try to get somebody to buy it ... knowing it does not work: The greater fool theory#RAForum#RAforum19Prikaži ovu nit -
#NIH#Chris Austin: We have to share the failures as much as the successes#RAForum#RAforum19Prikaži ovu nit -
$JNJ Melinda Richter notes the JLABs in DC at old Walter Reed campus#BARDA collaboration. https://jlabs.jnjinnovation.com/locations/jlabs-washington-dc …#RAForum#RAforum19Prikaži ovu nit - Još 47 drugih odgovora
Novi razgovor -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.